Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Non-Current Assets: 2010-2019

Historic Other Non-Current Assets for China Pharma Holdings (CPHI) over the last 6 years, with Dec 2019 value amounting to $109,908.

  • China Pharma Holdings' Other Non-Current Assets fell 55.69% to $222,996 in Q2 2020 from the same period last year, while for Jun 2020 it was $222,996, marking a year-over-year decrease of 55.69%. This contributed to the annual value of $109,908 for FY2019, which is 91.37% down from last year.
  • Latest data reveals that China Pharma Holdings reported Other Non-Current Assets of $109,908 as of FY2019, which was down 91.37% from $1.3 million recorded in FY2018.
  • In the past 5 years, China Pharma Holdings' Other Non-Current Assets registered a high of $1.3 million during FY2018, and its lowest value of $109,908 during FY2019.
  • Moreover, its 3-year median value for Other Non-Current Assets was $709,796 (2017), whereas its average is $697,881.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 79.48% in 2018, then crashed by 91.37% in 2019.
  • Over the past 4 years, China Pharma Holdings' Other Non-Current Assets (Yearly) stood at $1.1 million in 2016, then slumped by 34.81% to $709,796 in 2017, then soared by 79.48% to $1.3 million in 2018, then slumped by 91.37% to $109,908 in 2019.